NORTHERN TRUST CORP

Bank

Position in SNGX — Soligenix, Inc.

CIK 73124 CHICAGO, IL

Position in SNGX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$15,218

-$10,895 QoQ

Shares Held

38,046

+15621.5% QoQ

Ownership

0.175%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 13 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

NORTHERN TRUST CORP holds $7,812,079,440 across 423 Biotechnology names. SNGX ranks #412 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,486,478	$1,235,108,212
2	REGN	Regeneron Pharmaceuticals, Inc.	916,467	$571,453,829
3	ALNY	Alnylam Pharmaceuticals, Inc.	886,900	$266,983,504
4	RPRX	Royalty Pharma plc	4,718,859	$264,586,419
5	RVMD	Revolution Medicines, Inc.	1,117,110	$209,212,357
6	MRNA	Moderna, Inc.	2,985,329	$209,062,587
7	INCY	Incyte Corp	1,761,966	$199,736,460
8	CYTK	Cytokinetics Inc	1,647,345	$140,337,319

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$15,218	38,046	-34.4%	Shares	Defined	2026-08-13
2022-12-31	$26,113	58,031	0.0%	Shares	Defined	2023-02-13
2022-09-30	$25,533	58,031	+13.5%	Shares	Defined	2022-11-14
2022-06-30	$30,669	51,116	0.0%	Shares	Defined	2022-08-12
2022-03-31	$37,314	51,116	0.0%	Shares	Defined	2022-05-13
2021-12-31	$33,736	51,116	0.0%	Shares	Defined	2022-02-08
2021-09-30	$54,182	51,116	0.0%	Shares	Defined	2021-11-15
2021-06-30	$56,738	51,116	0.0%	Shares	Defined	2021-08-13
2021-03-31	$78,207	51,116	+5.5%	Shares	Defined	2021-05-12
2020-12-31	$62,035	48,465	0.0%	Shares	Defined	2021-02-11
2020-09-30	$86,752	48,465	+48.5%	Shares	Defined	2020-11-16
2020-06-30	$68,840	32,626	+58.2%	Shares	Defined	2020-08-14
2020-03-31	$34,646	20,623	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.